Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Bioavailability of Linvencorvir in Healthy Volunteers
NCT04729309Phase 1Completed
- Sponsor
- Roche
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of linvencorvir in Chronic Hepatitis B (CHB), sponsored by Roche. Primary endpoints: Percentage of Dose Excreted in Urine, Percentage of Dose Excreted in Feces and 2 more. Started Mar 2021; status: completed.
02
Drugs
linvencorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04729309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729309.